Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | SMMT | IONS | ||
| Company | Neurocrine Bioscienc | Summit Therapeu ADR | Ionis Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 135.21 | 19.85 | 80.50 | ||
| High | 135.54 | 19.90 | 82.21 | ||
| Low | 132.16 | 16.47 | 78.88 | ||
| Latest | 132.66 | 17.04 | 81.66 | ||
| Change | -3.13 | -2.64 | +1.36 | ||
| % Change | -2.31% | -13.41% | +1.69% | ||
| Volume | 1,923,000 | 8,794,899 | 1,570,600 | ||
| 20-Day Average Volume | 1,136,610 | 2,492,330 | 1,828,510 | ||
| Previous Close | 135.79 | 19.68 | 80.30 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 142.81 | 17.89 | 80.00 | ||
| 20-Day Raw Stochastic | 2.14% | 15.28% | 55.43% | ||
| 20-Day Relative Strength | 36.85 | 44.39 | 57.25 | ||
| Weighted Alpha | -3.98 | -11.46 | +126.37 | ||
| Today's Opinion | 8% Sell | 72% Sell | 100% Buy | ||
| Previous Opinion | 8% Buy | 40% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.45% since 01/05/26 | -2.29% since 01/05/26 | +3.99% since 01/05/26 | ||
| Low | 132.16 on 01/12/26 | 16.47 on 01/12/26 | 78.00 on 01/06/26 | ||
| High | 142.15 on 01/07/26 | 20.20 on 01/09/26 | 86.15 on 01/07/26 | ||
| 1-Month | |||||
| %Chg | -13.18% since 12/12/25 | -3.02% since 12/12/25 | +1.04% since 12/12/25 | ||
| Low | 132.16 on 01/12/26 | 16.47 on 01/12/26 | 76.08 on 01/05/26 | ||
| High | 155.55 on 12/15/25 | 20.20 on 01/09/26 | 86.15 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | -2.91% since 10/10/25 | -20.19% since 10/10/25 | +16.71% since 10/10/25 | ||
| Low | 132.16 on 01/12/26 | 15.62 on 11/21/25 | 66.66 on 11/10/25 | ||
| High | 160.18 on 12/08/25 | 25.49 on 10/13/25 | 86.15 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | -0.60% since 07/11/25 | -31.84% since 07/11/25 | +95.69% since 07/11/25 | ||
| Low | 123.67 on 08/08/25 | 15.62 on 11/21/25 | 40.03 on 08/07/25 | ||
| High | 160.18 on 12/08/25 | 30.98 on 08/05/25 | 86.15 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,539,078 | 15,176,232 | 13,006,511 | ||
| Shares Outstanding, K | 99,706 | 771,150 | 161,974 | ||
| Annual Sales | 2,355,300,000 | 0 | 705,140,000 | ||
| Annual Net Income | 341,300,000 | -221,320,000 | -453,900,000 | ||
| Last Quarter Sales | 794,900,000 | 0 | 156,720,000 | ||
| Last Quarter Net Income | 209,500,000 | -231,790,000 | -128,610,000 | ||
| 60-Month Beta | 0.28 | -1.51 | 0.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.04 on 10/28/25 | -0.31 on 10/20/25 | -0.61 on 10/29/25 | ||
| Latest Earnings Date | 02/05/26 | 02/23/26 | 02/18/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 32.49 | 0.00 | 0.00 | ||